Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Shares Outstanding (2019 - 2025)

Pliant Therapeutics (PLRX) has disclosed Shares Outstanding for 7 consecutive years, with $61.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 0.97% to $61.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.4 million through Dec 2025, up 0.97% year-over-year, with the annual reading at $61.4 million for FY2025, 0.97% up from the prior year.
  • Shares Outstanding for Q4 2025 was $61.4 million at Pliant Therapeutics, roughly flat from $61.4 million in the prior quarter.
  • The five-year high for Shares Outstanding was $61.4 million in Q3 2025, with the low at $35.7 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $52.0 million, with a median of $59.6 million recorded in 2023.
  • The sharpest move saw Shares Outstanding skyrocketed 5636.63% in 2021, then increased 0.92% in 2022.
  • Over 5 years, Shares Outstanding stood at $36.1 million in 2021, then surged by 35.63% to $48.9 million in 2022, then rose by 22.43% to $59.9 million in 2023, then rose by 1.57% to $60.9 million in 2024, then rose by 0.97% to $61.4 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $61.4 million, $61.4 million, and $61.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.